Warfarin Sodium
- Product NDC
- 63629-6342
- 11-digit product format
- 636296342
- Labeler code
- 63629
- Product ID
- 63629-6342_08e46109-a1b4-429e-a4e8-d01606144e17
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Warfarin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA202202
- Marketing category
- ANDA
- Marketing start
- 2010-08-16
- Marketing end
- 0000-00-00
- Substance
- WARFARIN SODIUM
- Active strength
- 1 mg/1
- Pharmacologic classes
- Vitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 63629-6342 | D | Discontinued by firm | 2026-08-17 | ||
| excluded package | package | 63629-6342 | 63629-6342-1 | D | Discontinued by firm | 2026-08-17 | |
| excluded package | package | 63629-6342 | 63629-6342-2 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 63629-6342-1 | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 63629-6342-2 | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 63629-6342-1 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 63629-6342-2 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202202-001 | WARFARIN SODIUM | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-002 | WARFARIN SODIUM | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-003 | WARFARIN SODIUM | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-004 | WARFARIN SODIUM | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-005 | WARFARIN SODIUM | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-006 | WARFARIN SODIUM | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-007 | WARFARIN SODIUM | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-008 | WARFARIN SODIUM | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-009 | WARFARIN SODIUM | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2013-03-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A202202-001 | AB |
| A202202-002 | AB |
| A202202-003 | AB |
| A202202-004 | AB |
| A202202-005 | AB |
| A202202-006 | AB |
| A202202-007 | AB |
| A202202-008 | AB |
| A202202-009 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A202202-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2013-03-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A202202-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2013-03-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A202202-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2013-03-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A202202-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2013-03-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A202202-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2013-03-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A202202-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2013-03-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A202202-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2013-03-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A202202-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2013-03-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A202202-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2013-03-04 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2013-03-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2013-03-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2013-03-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2013-03-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2013-03-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2013-03-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2013-03-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2013-03-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2013-03-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2013-03-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2013-03-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2013-03-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2013-03-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2013-03-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2013-03-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2013-03-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2013-03-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2013-03-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2013-03-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2013-03-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2013-03-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2013-03-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2013-03-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2013-03-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2013-03-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2013-03-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2013-03-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202202-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2013-03-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202202-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2013-03-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202202-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2013-03-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202202-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2013-03-04 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A202202-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A202202-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A202202-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A202202-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A202202-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A202202-006 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A202202-007 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A202202-008 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A202202-009 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-006 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-007 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-008 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202202-009 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-006 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-007 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-008 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202202-009 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-005 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-006 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-007 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-008 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202202-009 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202202-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202202-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202202-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202202-004 | AB | 1 | fd3edfee7708… |
FDA-Initiated Inactive NDC Indexing#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Warfarin Sodium | WARFARIN | A-S Medication Solutions | 541c9a70-adaf-4ef3-94ba-ad4e70dfa057 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | d7fb4290-ed37-4ed3-ae51-c400191961dc | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 51e98fb6-ba76-497e-95d8-fe895ef0b7ed | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | a4cf3107-5646-4b91-8aae-94548e4409ef | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 2fb8b8d5-f643-4069-8e47-5eae31a8fbc8 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 884cdbf6-0a52-4126-8e14-b0d7c9367e33 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 8eddba53-19c4-411b-b0d4-cb2f948ba125 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 2cbcc99d-9107-4d39-a1e9-e19305de8b5d | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 8ee94789-72d2-4c42-9dbd-0501e9767d97 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 545ec40d-2db1-4581-b3ec-ce195e5f5400 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Amneal Pharmaceuticals LLC | 558b7a0d-5490-4c1b-802e-3ab3f1efe760 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Coupler LLC | 52bacf1e-9ba8-7eca-e063-6394a90ab60b | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Coupler LLC | 5256c518-31bf-f73b-e063-6394a90a71da | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Coupler LLC | 2f2119e8-f583-ba16-e063-6394a90a13a2 | 2025-02-27 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Coupler LLC | 2d58d204-4976-95cf-e063-6394a90a34b7 | 2025-02-04 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Bryant Ranch Prepack | 8c876dd3-d659-479e-994c-39454c7028cc | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| WARFARIN SODIUM | WARFARIN SODIUM | Direct_Rx | efded00a-22b9-1da7-e053-2995a90a58ca | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Preferred Pharmaceuticals Inc. | ac117f50-8e67-4203-8d97-e53dd0687c20 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Bryant Ranch Prepack | 7fdfd870-e72d-4d88-b6d9-1d711b66d09f | 2024-01-02 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Bryant Ranch Prepack | 3dd9f8ce-75e0-426a-9d22-6af7742a0ca7 | 2023-12-14 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63629-6342-1 | 63629634201 | 60 TABLET in 1 BOTTLE (63629-6342-1) | 60 tablet | 2017-02-14 | 0000-00-00 | No | No | Current |
| 63629-6342-2 | 63629634202 | 90 TABLET in 1 BOTTLE (63629-6342-2) | 90 tablet | 2015-09-17 | 0000-00-00 | No | No | Current |